Canlyniadau Chwilio - Keith Wittstock

Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States gan Sang Hee Park, Mark Lambton, Jordana Schmier, Sara Hovland, Keith Wittstock, Vardhaman Patel

Connect to this object online.

Health disparities in psoriasis: geographic barriers to access in the United States gan Lauren Seigel, Sofia Shoaib, Keshia Maughn, Miran Foster, Shrushti Shah, Lakshmi Batchu, Keith Wittstock, Andrew Alexis

Connect to this object online.

Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for patients with anticitrullinated protein antibody- and rheumatoid factor-positive rh... gan Alexandrina Balanean, Cherrishe Brown-Bickerstaff, Andrew Klink, Vardhaman Patel, Hanke Zheng, Laetitia N'Dri, Keith Wittstock, Bruce Feinberg, Mark Chaballa, Vadim Khaychuk, Jill Kaufman, Prathamesh Pathak, Gordon Lam

Connect to this object online.